Clinical Trial Update: Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating the addition of one of two novel treatment agents to standard chemotherapy in acute myeloid leukemia and myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Cardiff University | Conditions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome | Phase 2, Phase 3 | Status: UNKNOWN